Rivaroxaban for the treatment of venous thromboembolism in patients with nephrotic syndrome and low AT-III: A pilot study

The anticoagulation effect of heparin requires adequate serum antithrombin (AT)-III levels. Rivaroxaban, however, exhibits its anticoagulation effects independent of AT-III. The aim of the present study was to evaluate the efficacy and safety of rivaroxaban as a treatment for venous thromboembolism...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lihua, Zhang, Haitao, Zhang, Jiong, Tian, Hong, Liang, Ju, Liu, Zhihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772665/
https://www.ncbi.nlm.nih.gov/pubmed/29399079
http://dx.doi.org/10.3892/etm.2017.5471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772665/
https://www.ncbi.nlm.nih.gov/pubmed/29399079
http://dx.doi.org/10.3892/etm.2017.5471

Ejemplares similares